First Manhattan’s AstraZeneca AZN Stock Holding History

First Manhattan’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$688K	Sell	3,554 -2	-0.1%	-$386	﹤0.01%	502
2025 Q4	$654K	Buy	3,556 +6	+0.2%	+$1.05K	﹤0.01%	504
2025 Q3	$545K	Sell	3,550 -108	-3%	-$16.3K	﹤0.01%	532
2025 Q2	$511K	Buy	3,658 +166	+5%	+$23.3K	﹤0.01%	531
2025 Q1	$513K	Buy	3,492 +299	+9%	+$43.3K	﹤0.01%	494
2024 Q4	$418K	Sell	3,193 -20	-0.6%	-$2.8K	﹤0.01%	534
2024 Q3	$501K	Hold	3,213	–	–	﹤0.01%	486
2024 Q2	$501K	Buy	3,213 +1	+0%	+$150	﹤0.01%	472
2024 Q1	$435K	Sell	3,212 -5	-0.2%	-$662	﹤0.01%	516
2023 Q4	$433K	Sell	3,217 -58	-2%	-$7.54K	﹤0.01%	508
2023 Q3	$444K	Hold	3,275	–	–	﹤0.01%	509
2023 Q2	$469K	Buy	3,275 +1,540	+89%	+$227K	﹤0.01%	498
2023 Q1	$241K	Sell	1,735 -952	-35%	-$128K	﹤0.01%	640
2022 Q4	$364K	Buy	2,687 +262	+11%	+$32.9K	﹤0.01%	574
2022 Q3	$265K	Buy	2,425 +475	+24%	+$60.3K	﹤0.01%	637
2022 Q2	$257K	Hold	1,950	–	–	﹤0.01%	665
2022 Q1	$258K	Hold	1,950	–	–	﹤0.01%	717
2021 Q4	$227K	Hold	1,950	–	–	﹤0.01%	715
2021 Q3	$234K	Sell	1,950 -600	-24%	-$69.8K	﹤0.01%	707
2021 Q2	$305K	Sell	2,550 -1,900	-43%	-$208K	﹤0.01%	656
2021 Q1	$442K	Buy	4,450 +387	+10%	+$38.9K	﹤0.01%	559
2020 Q4	$406K	Hold	4,063	–	–	﹤0.01%	552
2020 Q3	$445K	Hold	4,063	–	–	﹤0.01%	507
2020 Q2	$429K	Sell	4,063 -337	-8%	-$34.8K	﹤0.01%	516
2020 Q1	$393K	Hold	4,400	–	–	﹤0.01%	502
2019 Q4	$438K	Hold	4,400	–	–	﹤0.01%	547
2019 Q3	$392K	Hold	4,400	–	–	﹤0.01%	564
2019 Q2	$363K	Hold	4,400	–	–	﹤0.01%	594
2019 Q1	$355K	Hold	4,400	–	–	﹤0.01%	605
2018 Q4	$334K	Hold	4,400	–	–	﹤0.01%	603
2018 Q3	$348K	Hold	4,400	–	–	﹤0.01%	631
2018 Q2	$308K	Buy	4,400 +2,000	+83%	+$144K	﹤0.01%	622
2018 Q1	$167K	Sell	2,400 -1,800	-43%	-$125K	﹤0.01%	705
2017 Q4	$291K	Sell	4,200 -600	-13%	-$40.5K	﹤0.01%	647
2017 Q3	$325K	Hold	4,800	–	–	﹤0.01%	592
2017 Q2	$327K	Hold	4,800	–	–	﹤0.01%	594
2017 Q1	$298K	Hold	4,800	–	–	﹤0.01%	616
2016 Q4	$262K	Sell	4,800 -185	-4%	-$10.5K	﹤0.01%	617
2016 Q3	$327K	Hold	4,985	–	–	﹤0.01%	579
2016 Q2	$300K	Hold	4,985	–	–	﹤0.01%	601
2016 Q1	$280K	Hold	4,985	–	–	﹤0.01%	608
2015 Q4	$338K	Hold	4,985	–	–	﹤0.01%	575
2015 Q3	$317K	Hold	4,985	–	–	﹤0.01%	584
2015 Q2	$317K	Sell	4,985 -15	-0.3%	-$1.03K	﹤0.01%	603
2015 Q1	$342K	Sell	5,000 -91	-2%	-$6.32K	﹤0.01%	587
2014 Q4	$358K	Hold	5,091	–	–	﹤0.01%	577
2014 Q3	$363K	Sell	5,091 -400	-7%	-$29.3K	﹤0.01%	575
2014 Q2	$408K	Sell	5,491 -322,709	-98%	-$23.3M	﹤0.01%	553
2014 Q1	$21.3M	Sell	328,200 -98,829	-23%	-$6.38M	0.14%	118
2013 Q4	$25.4M	Hold	427,029	–	–	0.17%	106
2013 Q3	$22.2M	Hold	427,029	–	–	0.15%	109
2013 Q2	$21.6M	Buy	+427,029	New	+$21.7M	0.15%	110

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

First Manhattan's AZN Position: Q1 2026 in Review

First Manhattan reduced its AstraZeneca (AZN) stake by 0.06% in Q1 2026, selling an estimated $386 and leaving 3,554 shares worth $688K. The position accounts for ﹤0.01% of the portfolio, ranked #502.

First Manhattan first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $25.4M in Q4 2013. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

First Manhattan held 3,554 shares of AstraZeneca worth $688K as of Q1 2026.
First Manhattan sold 2 AstraZeneca shares in Q1 2026, an estimated $386.
AstraZeneca made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #502 holding.
First Manhattan first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
First Manhattan's AstraZeneca position peaked at $25.4M in Q4 2013.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.